Loading Events
This event has passed.

As a co-author of a famous article: ICH GCP goes risk-based, Artem Andrianov, Ph.D. will join the panel discussion at the PCT (organized by Informa) session: ICH E6 addendum: Risk-based Monitoring: What will this Mean for Clinical Trials?

PCT Interview

We invite everybody who is aware of upcoming GCP update to a discussion, where we elaborate an embracement plan of the RBM in the context of the new ICH initiative.